Citadel Advisors - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 106 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 12.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$9,882
-7.1%
12,200
-19.7%
0.00%
Q1 2023$10,640
-76.6%
15,200
-76.4%
0.00%
Q4 2022$45,481
-74.6%
64,420
-45.3%
0.00%
Q3 2022$179,000
-90.5%
117,687
-93.8%
0.00%
Q2 2022$1,891,000
+2455.4%
1,904,061
+3651.4%
0.00%
Q1 2022$74,000
-89.1%
50,756
-61.1%
0.00%
Q4 2021$682,000
-24.1%
130,615
-15.3%
0.00%
Q3 2021$899,000
+117.7%
154,218
+200.4%
0.00%
Q2 2021$413,000
-27.4%
51,345
-24.8%
0.00%
Q1 2021$569,000
+34.8%
68,305
+22.8%
0.00%
Q4 2020$422,000
-56.0%
55,639
-38.2%
0.00%
Q3 2020$959,000
-57.4%
89,987
-39.4%
0.00%
Q2 2020$2,253,000
+19.4%
148,600
-34.5%
0.00%
-100.0%
Q1 2020$1,887,000
-43.8%
226,737
+14.2%
0.00%0.0%
Q4 2019$3,357,000
+64.2%
198,609
+80.3%
0.00%0.0%
Q3 2019$2,045,000
-58.4%
110,151
-48.8%
0.00%
-50.0%
Q2 2019$4,920,000
+106.3%
215,026
+89.5%
0.00%
+100.0%
Q1 2019$2,385,000
+3.9%
113,487
-43.1%
0.00%
Q4 2018$2,296,000
-39.6%
199,620
+20.5%
0.00%
-100.0%
Q3 2018$3,802,000
+51.8%
165,667
+47.5%
0.00%
+200.0%
Q2 2018$2,504,000
+47.7%
112,321
+51.4%
0.00%
Q1 2018$1,695,000
-25.5%
74,200
-14.5%
0.00%
-100.0%
Q4 2017$2,275,000
+36.6%
86,800
+17.1%
0.00%
+100.0%
Q3 2017$1,666,000
-13.1%
74,156
+5.7%
0.00%
-50.0%
Q2 2017$1,918,000
+74.5%
70,158
+54.5%
0.00%
+100.0%
Q1 2017$1,099,000
+75.8%
45,400
+50.8%
0.00%
Q4 2016$625,000
-45.8%
30,100
-28.8%
0.00%
-100.0%
Q3 2016$1,153,000
+237.1%
42,300
+77.9%
0.00%
Q2 2016$342,000
+3.3%
23,772
+3.4%
0.00%
Q1 2016$331,000
+198.2%
23,000
+345.2%
0.00%
Q4 2015$111,000
-39.0%
5,166
-54.0%
0.00%
Q3 2015$182,000
+487.1%
11,228
+845.9%
0.00%
Q2 2015$31,000
+72.2%
1,187
+28.2%
0.00%
Q4 2014$18,000
-90.5%
926
-89.6%
0.00%
Q3 2014$190,000
+239.3%
8,862
+313.9%
0.00%
Q2 2014$56,0002,1410.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 2,213,326$18,386,00010.92%
ORACLE INVESTMENT MANAGEMENT INC 3,776,121$31,417,0004.70%
GRIFFIN ASSET MANAGEMENT, INC. 1,358,644$11,304,0001.44%
Selkirk Management LLC 288,805$2,403,0000.72%
Chicago Capital, LLC 1,593,126$13,255,0000.56%
Cannell & Co. 1,097,419$9,131,0000.29%
TCI Wealth Advisors, Inc. 55,586$462,0000.20%
Belpointe Asset Management LLC 197,853$1,646,0000.14%
ALGERT GLOBAL LLC 29,580$246,0000.08%
THOMPSON INVESTMENT MANAGEMENT, INC. 60,900$507,0000.08%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders